Heyne K, Weidinger S
Institut für Anthropologie und Humangenetik, Universität München.
Monatsschr Kinderheilkd. 1992 Nov;140(11):822-7.
The "Carbohydrate-deficient glycoprotein syndrome" is a recently discovered inborn error of complex carbohydrate metabolism. The disease involves a number of organ systems and various deficient glycoproteins. An abnormal isoform of serum transferrin is of diagnostic value.
We analysed the glycoprotein alpha-1-antitrypsin of two affected infants and their clinically healthy parents using high resolution isoelectric focusing technique. Besides normal isoforms of alpha-1-antitrypsin, we found an abnormal cathodic isoform ("CDG-alpha-1-antitrypsin") which represented almost half of the total amount of alpha-1-antitrypsin of the patients.
This new marker-glycoprotein suggests a defect of the production of biantennary and of triantennary N-glycans during an early step of their synthesis, resulting in monoantennary N-glycans. Also this marker-glycoprotein seems to be a specific biochemical diagnostic tool for discovering glycanosis CDG (Carbohydrate-deficient glycoprotein syndrome). The mode of inheritance is probably incomplete autosomal dominant. The same genetic defect of N-glycan synthesis may be present in more than one type of the hybrid molecule glycoprotein, and was also found in transferrin, resembling a "genetic back-pack", that might explain the multitude of clinical symptoms.
In view of these findings, we present novel systematics of those diseases that are due to inborn errors of N-glycan synthesis, and which we suggest to call "glycanoses".
“碳水化合物缺乏糖蛋白综合征”是最近发现的一种先天性复合碳水化合物代谢紊乱疾病。该疾病累及多个器官系统及多种糖蛋白缺乏。血清转铁蛋白的异常异构体具有诊断价值。
我们采用高分辨率等电聚焦技术分析了两名患病婴儿及其临床健康父母的糖蛋白α-1-抗胰蛋白酶。除了α-1-抗胰蛋白酶的正常异构体,我们还发现了一种异常的阴极异构体(“CDG-α-1-抗胰蛋白酶”),其占患者α-1-抗胰蛋白酶总量的近一半。
这种新的标记糖蛋白提示在双天线型和三天线型N-聚糖合成的早期步骤中存在缺陷,导致单天线型N-聚糖的产生。这种标记糖蛋白似乎也是发现糖基化疾病CDG(碳水化合物缺乏糖蛋白综合征)的一种特异性生化诊断工具。遗传方式可能为不完全常染色体显性遗传。N-聚糖合成的相同遗传缺陷可能存在于不止一种杂合分子糖蛋白中,并且在转铁蛋白中也有发现,类似于一个“遗传背包”,这可能解释了众多的临床症状。
鉴于这些发现,我们提出了那些由于N-聚糖合成先天性缺陷所致疾病的新分类方法,我们建议将这些疾病称为“糖基化疾病”。